Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies

Author： Sobhia M Elizabeth Grewal Baljinder K Bhat Jyotsna Rohit Shishir Punia Vijay

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.3, 2012-03, pp. : 325-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

By Vinik Aaron

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1547-1559

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of protein kinase C βII downregulates tristetraprolin expression in activated macrophages

By Leppänen T.

Inflammation Research, Vol. 57, Iss. 5, 2008-05 ,pp. : 230-240

Springer Publishing Company

Access to resources Recommend Favorite

Renoprotective and blood pressure-lowering effect of dietary soy protein via protein kinase C βII inhibition in a rat model of metabolic syndrome

By Palanisamy Nallasamy Viswanathan Periyasamy Ravichandran Mambakkam K. Anuradha Carani Venkataraman

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 1, 2010-01 ,pp. : 28-37

NRC Research Press

Access to resources Recommend Favorite

Protein Kinase C Inhibitors in the Treatment of Diabetic Retinopathy. Review

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 386-391

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Targeting of Protein Kinase C Receptor: Promising Route for Diabetic Retinopathy?

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 405-413

Bentham Science Publishers

Access to resources Recommend Favorite